Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alecensa
Alecensa
Roche wins FDA OK for targeted drug in early lung cancer
BioPharma Dive
Fri, 04/19/24 - 11:40 am
Roche
Alecensa
ALK inhibitors
FDA
non-small cell lung cancer
Lung Cancer Takes Center Stage at ESMO Congress 2023 With New Drugs, More Options
OBR Oncology
Fri, 10/20/23 - 10:05 am
ESMO
non-small cell lung cancer
Roche
Alecensa
AstraZeneca
Tagrisso
JNJ
Rybrevant
Genentech’s Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer
BioSpace
Wed, 10/18/23 - 10:17 am
Genentech
Alecensa
ALK inhibitors
non-small cell lung cancer
ESMO
ASCO: Roche's Alecensa stays on top of Xalkori with long-term survival showing
Fierce Pharma
Wed, 05/13/20 - 10:33 pm
Roche
ASCO 2020
Xalkori
Alecensa
Pfizer
ALK-positive non-small cell lung cancer
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
Fierce Pharma
Tue, 11/7/17 - 10:55 am
Roche
Alecensa
Pfizer
Novartis
lung cancer
Zykadia
Xalkori
ASCO17: Roche's Alecensa bests Xalkori in lung study
BioPharma Dive
Mon, 06/5/17 - 12:11 pm
Roche
Alecensa
Xalkori
ASCO 2017
Pfizer
lung cancer
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Novartis
Zykadia
Pfizer
Xalkori
Roche
Alecensa
non-small cell lung cancer
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Mon, 04/10/17 - 11:10 am
Roche
Genentech
Pfizer
Xalkori
Alecensa
non-small cell lung cancer
The FDA opens an inside track to let Novartis race ahead on Zykadia as Roche rivalry heats up
Endpoints
Thu, 02/23/17 - 09:23 am
FDA
Novartis
Zykadia
ALK-positive non-small cell lung cancer
non-small cell lung cancer
Roche
Alecensa
It's official: FDA shoots past 2014's new drugs record with Roche lung cancer med nod
BioPharma Dive
Mon, 12/14/15 - 11:03 am
FDA
Roche
Genentech
non-small cell lung cancer
Alecensa
drug approvals
FDA approves Genentech drug for advanced lung cancer
Yahoo/AP
Fri, 12/11/15 - 10:38 pm
FDA
Genentech
Alecensa
advanced lung cancer